Search results
AbbVie Inc. (NYSE:ABBV) Receives $174.31 Average Target Price from Brokerages
ETF DAILY NEWS· 19 hours agoShares of AbbVie Inc. (NYSE:ABBV – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the thirteen research firms that are presently covering the stock, MarketBeat ...
IPC Develops Consensus on Generalized Pustular Psoriasis
Medscape· 5 days agoThe IPC's definition and diagnostic criteria for GPP minimized the complexity of clinical...
Americans Got Drug-Resistant Infections After Stem Cell Treatments in Mexico
US News & World Report· 3 days agoThe germ involved in all three cases was Mycobacterium abscessus, explained a team led by Dr. Minh-Vu Nguyen, an infectious disease specialist at National Jewish Health in Denver. "Stem cell ...
MoonLake Immunotherapeutics’ (MLTX) Buy Rating Reiterated at Needham & Company LLC
ETF DAILY NEWS· 2 days agoNeedham & Company LLC reissued their buy rating on shares of MoonLake Immunotherapeutics (NASDAQ:MLTX – Free Report) in a research report sent to investors on Wednesday morning, Benzinga reports ...
MoonLake Immunotherapeutics Reports Q1 2024 Financial Outcomes
Guru Focus· 5 days agoReported Net Loss: $13.98 million for Q1 2024, below the estimated net loss of $13.21 million.Earnings Per Share (EPS): Recorded a loss of $0.22 per share, bel
Johnson & Johnson (NYSE:JNJ) Stake Increased by Sheets Smith Wealth Management
ETF DAILY NEWS· 3 days agoSheets Smith Wealth Management raised its stake in Johnson & Johnson (NYSE:JNJ – Free Report) by 11.6% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 13,821 ...
MoonLake Immunotherapeutics (NASDAQ:MLTX) Receives Average Recommendation of “Moderate Buy” from...
ETF DAILY NEWS· 6 days agoShares of MoonLake Immunotherapeutics (NASDAQ:MLTX – Get Free Report) have earned an average recommendation of “Moderate Buy” from the twelve research firms that are presently covering the firm ...
Analysts Set Ventyx Biosciences, Inc. (NASDAQ:VTYX) PT at $21.75
ETF DAILY NEWS· 4 days agoVentyx Biosciences, Inc. (NASDAQ:VTYX – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the nine research firms that are currently covering the company, MarketBeat ...
Citizens Business Bank Sells 329 Shares of Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 7 days agoCitizens Business Bank lowered its holdings in Johnson & Johnson (NYSE:JNJ – Free Report) by 8.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities ...
Fisher Asset Management LLC Acquires 127,228 Shares of Bristol-Myers Squibb (NYSE:BMY)
ETF DAILY NEWS· 6 days agoFisher Asset Management LLC increased its holdings in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 130.7% in the 4th quarter, according to the company in its most recent filing with the ...